ArticleProceedings of the National Academy of Sciences of the United States of America2025

CBX2 suppresses interferon signaling to diminish tumor immunogenicity via a noncanonical corepressor complex.

Yanxun Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.